BioNTech - International Biopharmaceutical Industry

news

Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Dive Brief: Moderna has asked the Food and Drug Administration to clear a fourth dose of its COVID-19 vaccine for adults 18 and over, a broader request than Pfizer...

21 March 2022 news adults | BioNTech

Continue Reading →

news

With new trial, Pfizer and BioNTech will test whether an omicron vaccine is needed

Dive Brief: Pfizer and BioNTech have begun enrolling patients in a study testing a new version of their COVID-19 vaccine specifically tailored to the omicron varia...

27 January 2022 news BioNTech | COVID-19

Continue Reading →

news

Omicron cuts Pfizer vaccine’s potency, but data show booster may restore protection

Three doses of Pfizer and BioNTech's COVID-19 vaccine may protect against the new omicron variant similarly well as two doses did against the original coronavirus str...

10 December 2021 news BioNTech | booster

Continue Reading →

news

Pfizer, BioNTech to seek full approval as COVID-19 vaccine efficacy holds up in young teens

The results disclosed by Pfizer and BioNTech on Monday could support full approvals in the U.S. and elsewhere, which in turn could help bolster vaccination rates amon...

26 November 2021 news BioNTech | COVID-19 vaccine

Continue Reading →

news

Pfizer again asks FDA to authorize COVID-19 boosters for all adults

Agency advisers had opposed a broad booster dose clearance in September, leading the FDA to limit use to older adults and those at high risk of COVID-19. Pfizer and ...

15 November 2021 news adults | BioNTech

Continue Reading →

news

Under pressure to share technology, Moderna to build vaccine factory in Africa

The announcement from Moderna comes amid criticism of the drugmaker, and other Western companies with authorized coronavirus vaccines, for not doing more to share the...

8 October 2021 news Africa | BioNTech

Continue Reading →

news

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

The success of the mRNA vaccines developed by Moderna and BioNTech has drawn significant attention, and new funding, to the technology that allows drug developers to ...

30 September 2021 news AstraZeneca | BioNTech

Continue Reading →

news

FDA grants full approval to Pfizer, BioNTech’s coronavirus vaccine

The Food and Drug Administration on Monday granted full approval to Pfizer and BioNTech's coronavirus vaccine, a long-awaited decision that government officials hope ...

27 August 2021 news BioNTech | coronavirus vaccine

Continue Reading →